SCHEMBL6425324

SCHEMBL6425324

CCc1nc2cc(S(C)(=O)=O)c(Cl)cc2n1-c1c[c]ccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 3/20 0.35
NR1H3 Q13133 3/20 0.35
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
PDE10A Q9Y233 2/20 0.33
CYP1A2 P05177 1/20 0.33
CNR2 P34972 2/20 0.32
SMN1; SMN2 Q16637 3/20 0.31
MAPT P10636 2/20 0.31
HTT P42858 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899886 0.88 PTGDR2 (0.32) NR1H2NR1H3CA12CA1CA2
SCHEMBL7100254 0.81 PDE10A (0.34) PDE10ACYP1A2ESR1ESR2
SCHEMBL7099453 0.81 NR1H2 (0.42) NR1H2NR1H3PDE10ACYP1A2CNR2
SCHEMBL27600064 0.80 PDE10A (0.32) PDE10ACYP1A2ESR1ESR2HPGD
SCHEMBL27618366 0.80 DCTPP1 (0.40) CA12CA9SMN1; SMN2MAPTHTT
SCHEMBL5772661 0.80 PPARG (0.36) CA12CA1CA2CA3CA4
SCHEMBL7097335 0.80 NR1H2 (0.37) NR1H2NR1H3PDE10ACYP1A2CNR2
SCHEMBL27618382 0.79 PDE10A (0.38) PDE10ACYP1A2ESR1ESR2ALDH1A1
SCHEMBL27582732 0.78 CYP1A2 (0.41) PDE10ACYP1A2SMN1; SMN2MAPT
SCHEMBL27600071 0.78 PDE10A (0.40) PDE10ACYP1A2HPGDTBXA2RALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1476448-A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents ������ҩ�����޹�˾ 2004-02-18 CN claimed
EP-1499305-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES Pfizer Japan Inc. (JP) 2005-01-26 EP disclosed
CN-1476448-A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents ������ҩ�����޹�˾ 2004-02-18 CN disclosed
WO-2003086371-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed
EP-1326606-A2 EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS PFIZER PHARMACEUTICALS INC. (JP) 2003-07-16 EP disclosed
WO-2002032422-A2 EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS PFIZER PHARMACEUTICALS INC. (JP) 2002-04-25 WO disclosed